Average Price Target: $80.20
▲ +32.65% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Loblaw Companies in the last 3 months. The average price target is $80.20, with a high forecast of $96.00 and a low forecast of $69.00. The average price target represents a 32.65% upside from the last price of $60.46.
The current consensus among 7 contributing investment analysts is to buy stock in Loblaw Companies. This rating has held steady since March 2020, when it changed from a Hold consensus rating.
Loblaw Companies Limited, a food and pharmacy company, engages in the grocery, pharmacy, health and beauty, apparel, general merchandise, financial services, and wireless mobile products and services businesses in Canada. It operates in two segments, Retail and Financial Services. The Retail segment operates corporate and franchise-owned retail food, and associate-owned drug stores. This segment also includes in-store pharmacies, other health and beauty product stores, apparel stores, and other general merchandise stores. The Financial Services segment provides credit card and banking services, the PC Optimum program, insurance brokerage services, and telecommunication services. It also offers PC Healthapp, a health and wellness app that provides Canadians with access to healthcare resources and support. Loblaw Companies Limited provides its products and services under various brands. The company was founded in 1919 and is headquartered in Brampton, Canada. Loblaw Companies Limited is a subsidiary of George Weston Limited.